-
Mashup Score: 0
Providers must develop and integrate an ambulatory strategy into their overarching cardiovascular strategic plan, whether through joint ventures, acquisition, or other alignment structures with existing ASCs, or through investment into their own facility(ies), because this growing shift is imminent in all markets for cardiology.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 0
Providers must develop and integrate an ambulatory strategy into their overarching cardiovascular strategic plan, whether through joint ventures, acquisition, or other alignment structures with existing ASCs, or through investment into their own facility(ies), because this growing shift is imminent in all markets for cardiology.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine News, Cardiology News and JournTweet-
🚨 "A Shift in Cardiovascular Care: ASCs, PAD, and PVI" 🚨 Michael Church, Director, and Amy Newell, Senior Vice President at Corazon, Inc. Is this the next big transformation in vascular health? 🔗 Read more: https://t.co/e7TXukIJK1 @InvasiveCardiol #cardiotwitter https://t.co/2Djv6xhg3V
-
-
Mashup Score: 2
Providers must develop and integrate an ambulatory strategy into their overarching cardiovascular strategic plan, whether through joint ventures, acquisition, or other alignment structures with existing ASCs, or through investment into their own facility(ies), because this growing shift is imminent in all markets for cardiology.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine News, CardiologistsTweet-
🚨 "A Shift in Cardiovascular Care: ASCs, PAD, and PVI" 🚨 Michael Church, Director, and Amy Newell, Senior Vice President at Corazon, Inc. Is this the next big transformation in vascular health? 🔗 Read more: https://t.co/TPXTT6syCU @InvasiveCardiol #cardiotwitter https://t.co/JVHwmXlGkK
-
-
Mashup Score: 1
Left ventricular assist devices, which are mechanical heart pumps, are an important treatment for patients with advanced heart failure.LVADs assist weakened left ventricles to enable the heart to pump blood properly, and can be used as permanent solutions to the heart failure condition or used to stabilize a patient’s heart failure condition as a bridge to transplantation. LVADs are complex
Source: www.healio.comCategories: General Medicine News, CardiologistsTweet-
Healio spoke with Francis D. Pagani, MD, PhD, why LVADs are so challenging, how the new device works and how patients with advanced HF might benefit if the trial is successful @umichCVC #cardiotwitter https://t.co/Ko9FfTrP7H
-
-
Mashup Score: 2
Danon disease is a rare, X-linked, monogenic cardiomyopathy caused by mutations in the lysosomal-associated membrane 2 gene (LAMP2), which encodes the LAMP2 protein. In male patients, the predomina…
Source: www.nejm.orgCategories: General Medicine News, CardiologistsTweet-
Update on Danon's RP-A501 gene therapy phase I Things are going well Paper is here https://t.co/0W4Qc5eKWp #CardioTwitter https://t.co/0k7lUoIbhK
-
-
Mashup Score: 0Rhode Island Hospital Cardiac Catheterization Lab - 2 day(s) ago
Rhode Island Hospital’s interventional cardiologists performed the first outpatient cardiac catheterization in New England and were among the first in the United States to perform percutaneous coronary intervention (PCI). We have a cath lab that is located just adjacent to the emergency department’s critical care unit.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine News, CardiologistsTweet-
Cath Lab Spotlight: Rhode Island Hospital Cardiac Cath Lab https://t.co/2cMVH93Ent @JDawnAbbott1 #cardiotwitter @invasivecardiol https://t.co/0WwaskbbO0
-
-
Mashup Score: 1Beyonttra | European Medicines Agency (EMA) - 19 day(s) ago
On 12 December 2024, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Beyonttra 1, intended for the treatment of transthyretin amyloidosis in adult patients with cardiomyopathy. The applicant for this medicinal product is BridgeBio Europe B.V. Beyonttra will be available as 356 mg film-coated tablet. The active substance of BEYONTTRA is acoramidis hydrochloride, belonging to the pharmacothe
Source: www.ema.europa.euCategories: General Medicine News, CardiologistsTweet-
Acoramidis is Beyonttra in Europe US: Attruby #CardioTwitter https://t.co/XwsGpFb9pi. https://t.co/6bN8TkYZIm
-
-
Mashup Score: 4
Ready to explore a new professional opportunity? Browse the list below of featured jobs and take the next step in your career! For a filtered job search and to sign up for customized job alerts and access career resources, visit ACC’s Cardiology Careers page. Want to get the latest featured jobs delivered right to your inbox? Create your job seeker account on the Cardiology Careers portal to get the Job Flash â„¢ email twice a
Source: www.acc.orgCategories: General Medicine News, Cardiology News and JournTweet-
Are you ready to explore a new professional opportunity? Explore ACC's Featured Jobs for August 2023 and take the next step toward a new career today! https://t.co/EyspOOEhIb #CardioTwitter https://t.co/73reZ7T9bZ
-
-
Mashup Score: 3Are Antibiotics a Reasonable Alternative for Uncomplicated Appendicitis in Children? - 20 day(s) ago
In recent trials, researchers have explored antibiotic therapy for uncomplicated appendicitis as an alternative to appendectomy in adults, but large
Source: www.jwatch.orgCategories: General Medicine News, General HCPsTweet-
Antithrombotic Therapy for Atrial Fibrillation and ACS or PCI: Choosing a Regimen Based on the Totality of Events https://t.co/Ar10fLZgjN @bbikdeli #CardioTwitter https://t.co/MmHkMvlsQd
-
-
Mashup Score: 0The Takeruâ„¢ PTCA Balloon Dilatation Catheter for Pre Intravascular Lithotripsy (IVL) - 23 day(s) ago
Deliverability of IVL devices can be challenging. Thankfully, the low-profile design coupled with increased pushability of Terumo’s Takeruâ„¢ PTCA Balloon Dilatation Catheter facilitates the use of IVL in heavily calcified lesions.Â
Source: www.hmpgloballearningnetwork.comCategories: General Medicine News, CardiologistsTweet-
The Takeruâ„¢ PTCA Balloon Dilatation Catheter for Pre Intravascular Lithotripsy (IVL) By Daniel Vilchez, MD https://t.co/hwGhRuG1Zl #cardiotwitter @invasivecardiol
-
🚨 "A Shift in Cardiovascular Care: ASCs, PAD, and PVI" 🚨 Michael Church, Director, and Amy Newell, Senior Vice President at Corazon, Inc. Is this the next big transformation in vascular health? 🔗 Read more: https://t.co/1FXChIuDdv #cardiotwitter https://t.co/trE3R1EFg0